Key Takeaways
- Shares of Rocket Lab declined 9% during pre-market hours following Q2 2026 financial results
- Quarterly revenue reached an all-time high of $234 million, representing 62% growth year-over-year and surpassing projections
- Forward-looking Q3 GAAP gross margin forecast of 29%–31% significantly underperformed Wall Street’s ~37.6% projection
- Shares had already climbed approximately 27% during the week preceding the earnings announcement, creating vulnerability
- Company boasts record order backlog of $2.36 billion alongside a major $397 million Space Force award
Shares of Rocket Lab experienced a sharp 9% decline in pre-market activity Tuesday following its Q2 2026 financial disclosure, which failed to satisfy investor expectations regarding profit margins.
The aerospace firm delivered record-setting quarterly revenue of $234 million, representing a 62% increase from the prior-year period and narrowly exceeding the $232 million analyst forecast. However, this top-line achievement proved insufficient to support share prices.
The adjusted earnings per share registered a loss of $0.08, falling short of Wall Street projections. The more significant concern stemmed from Q3 GAAP gross margin guidance ranging from 29%–31%, substantially below consensus estimates hovering around 37.6%.
Shares had already appreciated approximately 27% during the seven-day period before the earnings release. This pre-announcement rally left the stock susceptible to profit-taking when profitability metrics underwhelmed.
The margin compression appears linked to changes in revenue composition. Satellite platform sales, which carry lower profit margins, represented an expanded portion of Space Systems revenue during the quarter.
The non-GAAP gross margin for Q2 reached 41.5%, surpassing the 38% analyst projection. Nevertheless, the disappointing forward guidance eclipsed this positive result.
Third Quarter Projections and Iridium Deal Concerns
Company leadership projected Q3 revenue in the range of $250 million to $265 million, substantially exceeding the $235.9 million consensus forecast. However, the anticipated gross margin decline dominated investor attention and drove selling pressure.
Non-GAAP gross margin expectations for Q3 sit between 35% and 37%, representing a decline from the 41.5% level achieved last quarter. Adjusted EBITDA loss is forecast in the $17 million to $23 million range.
The upcoming $8 billion Iridium transaction continues to inject additional uncertainty into the investment narrative. Approximately 41 million preferred shares are factored into Q3 projections, heightening shareholder dilution anxieties.
The sell-off momentum that began in Monday’s after-hours session carried through into Tuesday’s pre-market trading. The broader equity markets offered little support, with both the S&P 500 and Nasdaq trading relatively unchanged.
Contract Pipeline and Order Book Remain Robust
Rocket Lab closed the quarter with an all-time high backlog totaling $2.36 billion. This figure encompasses over 90 scheduled missions within its launch queue.
The previous week brought news of a $397 million contract from the U.S. Space Force, encompassing development work and launch services for Flatellite spacecraft using the Neutron launch vehicle.
Progress on Neutron’s Stage 1 tank manufacturing continues according to schedule, with delivery to the launch facility anticipated in Q4. This development milestone represents a critical component of the company’s extended growth trajectory.
The company also finalized its acquisitions of Mynaric and Motiv earlier in the year, incorporating additional capabilities into its spacecraft and space systems offerings.
Wall Street analysts maintain a Strong Buy consensus rating on the stock, with 13 Buy recommendations and 4 Hold ratings issued over the past three months. The average analyst price target stands at $110.53, suggesting approximately 38% potential upside from Monday’s closing price.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
